Genetic polymorphisms of vascular endothelial growth factor and angiopoietin 2 in retinopathy of prematurity

Curr Eye Res. 2006 Jul-Aug;31(7-8):685-90. doi: 10.1080/02713680600801123.

Abstract

Angiogenic factors such as vascular endothelial growth factor (VEGF) and angiopoietin 2 (Ang2) contribute to development of retinopathy of prematurity (ROP). We aimed to test whether polymorphisms of these factors are associated with ROP. VEGF(-2578) and Ang2(-35) polymorphisms were analyzed with PCR-RFLP method in 200 preterm infants without ROP or with ROP stages 1-5. Our results suggest that there is no association between carrier state of VEGF(-2578) and Ang2(-35) and risk of ROP in preterm infants. The prevalence of VEGF(-2578) "A" allele was lower in preterm boys with severe ROP (stages 4-5) than in those without or with mild ROP (stages 1-3).

Publication types

  • Comparative Study
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Angiopoietin-2 / genetics*
  • DNA / genetics
  • Female
  • Follow-Up Studies
  • Gene Frequency
  • Genotype
  • Humans
  • Infant, Newborn
  • Male
  • Polymerase Chain Reaction
  • Polymorphism, Genetic*
  • Prognosis
  • Retinopathy of Prematurity / genetics*
  • Retinopathy of Prematurity / metabolism
  • Retrospective Studies
  • Risk Factors
  • Severity of Illness Index
  • Vascular Endothelial Growth Factor A / genetics*

Substances

  • Angiopoietin-2
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • DNA